• DHA shows a protective effect against neonatal hyperbilirubinemia encephalopathy

    • 06/08/2018

    Bilirubin (a derivative of haemoglobin) is a highly toxic pigment for biological systems, particularly the central nervous system. Bilirubin encephalopathy (hyperbilirubinemia encephalopathy or bilirubin-induced brain dysfunction) is a severe complication of neonatal jaundice and is associated with...

    Read more


  • Parenteral nutrition with n-3 PUFA in patients with gastrointestinal cancer

    • 06/13/2018

    Most patients with gastrointestinal (GI) cancer suffer varying degrees of malnutrition and deterioration to their immune function. This not only affects healing of the anastomotic stoma, but also worsens the patient’s prognosis, increasing the risk of secondary post-surgical infections and other...

    Read more


  • Omega-3 in osteoarthritis

    • 06/28/2018

    Osteoarthritis (OA) is the most prevalent form of arthritis worldwide and the fastest growing cause of disability; 18% of women and 9.6% of men over 60 suffer symptomatic AO and a quarter of them have difficulty in doing activities of daily living. It is estimated that by 2050, 130 million people...

    Read more


  • EPA and DHA could counteract exercise-induced muscle and nerve damage

    • 06/28/2018

    Dietary supplementation is important for improving and maintaining athletic performance. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are known to improve fatigue and stamina, and also maintain immune function; furthermore, they seem to be effective in delayed-onset muscle soreness...

    Read more